Sarcomas

SCIENTIFIC COORDINATOR: Paolo G. Casali, IT
                                     

The online course on soft tissue and bone sarcomas is addressed to an International audience of clinical oncologists interested in advancing their knowledge and skills on the clinical management of these tumors in a multidisciplinary context.
 
Taking into account that “networking” is the keyword  to improve quality of care of rare cancers, the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing  the collaboration among oncologists of different countries who are already part of the network or willing to be part of it in the near future.
 
The course will also be part of the “Career development educational pathway on Rare Adult Solid Cancers” (more information about the full educational programme on rare cancers will be published on the ESO website in the coming months).

FORMAT
The course is made up of a series of pre-recorded lectures (available online from 1 July 2021).
 
LEARNING OBJECTIVES 
- To provide an overview of current multidisciplinary state-of-the-art treatment of sarcomas
- To establish connections for future distance clinical mentoring/tutoring/networking
 
PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English
 
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
 
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 9 CME credits have been granted to this event.
The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
CME credits will be available until 30 June 2023.

 

ESCO CREDITS
The course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 6 ESCO credits.
Visit www.esco.org for information on how to join ESCO.
 
REGISTRATION
Registration for the course is required but free (you can find the registration link on the right).
Registration will be confirmed by e-mail.
 
ORGANISING SECRETARIAT
Marina Fregonese
email: mfregonese@eso.net
phone: +39 02 23902106
 
SOCIAL MEDIA
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology

The epidemiology of sarcomas

01/07/2021

Expert: Annalisa Trama, IT

The natural history of sarcomas

01/07/2021

Expert: Paolo Giovanni Casali, IT

The pathology of sarcomas

01/07/2021

Expert: Angelo Paolo Dei Tos, IT

Surgery of sarcomas

01/07/2021

Expert: Alessandro Gronchi, IT

Radiation therapy of sarcomas

01/07/2021

Expert: Rick Haas, NL

The medical therapy of soft tissue sarcomas

01/07/2021

Expert: Paolo Giovanni Casali, IT

The multidisciplinary approach to GIST

01/07/2021

Expert: Alessandro Gronchi, IT

The medical therapy of GIST

01/07/2021

Expert: Jean-Yves Blay, FR

Principles of treatment of osteosarcoma

01/07/2021

Expert: Stefan Bielack, DE

Principles of treatment of Ewing's sarcoma

01/07/2021

Expert: Sandra Strauss, UK

Principles of treatment of rhabdomyosarcoma

01/07/2021

Expert: Veronique Minard-Colin, FR

Uterine sarcomas

01/07/2021

Expert: Isabelle Ray-Coquard, FR

Rare and ultrarare soft tissue and bone sarcomas

01/07/2021

Expert: Paolo Giovanni Casali, IT
Stefan Bielack

Olgahospital, Stuttgart, Germany

Jean-Yves Blay

Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France

Paolo Giovanni Casali

National Cancer Institute - IRCCS Foundation, Milan, Italy

Angelo Paolo Dei Tos

Pathologist, University of Padua School of Medicine, Padua, Italy

Alessandro Gronchi

National Cancer Institute - IRCCS Foundation, Milan, Italy

Rick Haas

The Netherlands Cancer Institute, Amsterdam, The Netherlands

Veronique Minard-Colin

Institut Gustave Roussy, Villejuif, France

Isabelle Ray-Coquard

Léon Bérard Center, Lyon, France

Sandra Strauss

Consultant Medical Oncologist, UCL Cancer Institute, London, United Kingdom

Annalisa Trama

National Cancer Institute - IRCCS Foundation, Milan, Italy